Efficacy and tolerability of 100 mg of lasmiditan for migraine: A multi-center, prospective observational real-world study in Japan
Ryotaro Ishii(Kyoto Prefectural University of Medicine), Tsubasa Takizawa(Keio University), Kei Ishizuchi(Keio University Hospital), Jin Nakahara(Keio University Hospital), Ryosuke Fukazawa(Kyoto Prefectural University of Medicine), Narumi Watanabe(Keio University Hospital), Meesha Trivedi(Texas Tech University)
Cited by 8
Related Papers
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|174
Spreading depolarizations trigger caveolin‐1–dependent endothelial transcytosis
|Annals of Neurology|2018|107
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
|Cephalalgia|2024|107
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
|Cephalalgia|2024|106
Spreading depression as a preclinical model of migraine
|The Journal of Headache and Pain|2019|104